AI-based Drug Discovery
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
243
NCT06253871
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 25, 2024
Completion: Mar 31, 2028
Loading map...